Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

Inclusion Criteria: * Male and female patients of at least 18 years at the time of consent * Patients with a venous leg ulcer (Ulcus cruris) * Patients with a chronic leg ulcer * Females of childbearing potential who are willing to comply with any applicable contraceptive requirements of the protocol * Negative pregnancy test * Satisfactory medical assessment * Ability to provide written informed consent * Signed declaration of consent * Willingness to co-operate Exclusion Criteria: * Pregnant or lactating women and women not using contraception * Known history of alcohol or drug abuse * Use of any antibiotic medication within the last 7 days prior to the first dose * Patients with serious concomitant disease * Patients with a coagulation disorder * Known history of allergic reactions attributed to octenisept® or one of its compounds * Participation in another clinical trial within the last 30 days before randomization * Concomitant treatment with other preparations that interfere with the trial preparation or the disease * Absence of declaration of consent * Doubt about willingness to co-operate * Non-fulfilment of the inclusion criteria